| Disease | Target Count |
|---|---|
| Prostatic Neoplasms | 471 |
| Disease | Target Count | P-value |
|---|---|---|
| ovarian cancer | 8491 | 1.5e-08 |
| malignant mesothelioma | 3163 | 6.1e-08 |
| osteosarcoma | 7933 | 8.5e-07 |
| pediatric high grade glioma | 2712 | 7.0e-06 |
| sonic hedgehog group medulloblastoma | 1482 | 1.2e-05 |
| medulloblastoma, large-cell | 6234 | 1.4e-04 |
| atypical teratoid / rhabdoid tumor | 4369 | 2.4e-04 |
| psoriasis | 6685 | 3.0e-04 |
| primitive neuroectodermal tumor | 3031 | 4.0e-04 |
| glioblastoma | 5572 | 5.8e-04 |
| intraductal papillary-mucinous adenoma (IPMA) | 2956 | 6.2e-04 |
| tuberculosis and treatment for 6 months | 686 | 1.8e-03 |
| astrocytic glioma | 2241 | 6.9e-03 |
| subependymal giant cell astrocytoma | 2287 | 1.6e-02 |
| ependymoma | 2514 | 2.4e-02 |
| oligodendroglioma | 2849 | 2.9e-02 |
| spina bifida | 1064 | 3.6e-02 |
| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| Angelman syndrome | 38 | 3.594 | 1.8 |
| Prader-Willi syndrome | 45 | 3.328 | 1.7 |
| Paraplegia | 71 | 3.069 | 1.5 |
| Disease | log2 FC | p |
|---|---|---|
| malignant mesothelioma | -3.700 | 6.1e-08 |
| astrocytic glioma | -2.600 | 6.9e-03 |
| ependymoma | -2.400 | 2.4e-02 |
| oligodendroglioma | -1.800 | 2.9e-02 |
| psoriasis | -2.400 | 3.0e-04 |
| glioblastoma | -2.700 | 5.8e-04 |
| osteosarcoma | -2.476 | 8.5e-07 |
| sonic hedgehog group medulloblastoma | -2.100 | 1.2e-05 |
| atypical teratoid / rhabdoid tumor | -2.200 | 2.4e-04 |
| medulloblastoma, large-cell | -3.000 | 1.4e-04 |
| primitive neuroectodermal tumor | -2.100 | 4.0e-04 |
| tuberculosis and treatment for 6 months | -1.100 | 1.8e-03 |
| intraductal papillary-mucinous adenoma (... | 1.200 | 6.2e-04 |
| pediatric high grade glioma | -2.700 | 7.0e-06 |
| subependymal giant cell astrocytoma | -2.383 | 1.6e-02 |
| spina bifida | -1.860 | 3.6e-02 |
| ovarian cancer | -2.300 | 1.5e-08 |
| PMID | Text | |
|---|---|---|
| 19738379 | Study demonstrates that both human NPAL3 and mouse NPAL3 are ubiquitously expressed and encode highly conserved proteins |
MDGSHSAALKLQQLPPTSSSSAVSEASFSYKENLIGALLAIFGHLVVSIALNLQKYCHIRLAGSKDPRAY 1 - 70 FKTKTWWLGLFLMLLGELGVFASYAFAPLSLIVPLSAVSVIASAIIGIIFIKEKWKPKDFLRRYVLSFVG 71 - 140 CGLAVVGTYLLVTFAPNSHEKMTGENVTRHLVSWPFLLYMLVEIILFCLLLYFYKEKNANNIVVILLLVA 141 - 210 LLGSMTVVTVKAVAGMLVLSIQGNLQLDYPIFYVMFVCMVATAVYQAAFLSQASQMYDSSLIASVGYILS 211 - 280 TTIAITAGAIFYLDFIGEDVLHICMFALGCLIAFLGVFLITRNRKKPIPFEPYISMDAMPGMQNMHDKGM 281 - 350 TVQPELKASFSYGALENNDNISEIYAPATLPVMQEEHGSRSASGVPYRVLEHTKKE 351 - 406 //
| PMID | Year | Title | |
|---|---|---|---|
| 25416956 | 2014 | A proteome-scale map of the human interactome network. | |
| 19738379 | 2009 | Targeted disruption of the mouse Npal3 gene leads to deficits in behavior, increased IgE levels, and impaired lung function. | |
| 19690332 | 2009 | Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. | |
| 17974005 | 2007 | The full-ORF clone resource of the German cDNA Consortium. | |
| 16710414 | 2006 | The DNA sequence and biological annotation of human chromosome 1. | |
| 16344560 | 2006 | Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. | |
| 15489334 | 2004 | The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). | |
| 14702039 | 2004 | Complete sequencing and characterization of 21,243 full-length human cDNAs. | |
| 12477932 | 2002 | Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. | |
| 9110174 | 1997 | Large-scale concatenation cDNA sequencing. | |
| 8619474 | 1996 | A "double adaptor" method for improved shotgun library construction. |
